UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

BMC palliative care, 2019-05, Vol.18 (1), p.42-42, Article 42

2019

Volltextzugriff (PDF)

Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?

International journal of gynecological cancer, 2017-03, Vol.27 (3), p.543-549

2017

Volltextzugriff (PDF)

Immature uterine teratoma associated with uterine inversion

Rare tumors, 2014-08, Vol.6 (3), p.5530-113

2014

Volltextzugriff (PDF)

Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer

American journal of physiology. Heart and circulatory physiology, 2019-07, Vol.317 (7), p.H1-H12

2019

Volltextzugriff (PDF)

Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection

Lung cancer (Amsterdam, Netherlands), 2022-02, Vol.164, p.69-75

2022

Volltextzugriff (PDF)

Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis

Thyroid (New York, N.Y.), 2016-03, Vol.26 (3), p.414-419

2016

Volltextzugriff (PDF)

Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?

European journal of obstetrics & gynecology and reproductive biology, 2015-09, Vol.192, p.86-89

2015

Volltextzugriff (PDF)

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Science translational medicine, 2020-09, Vol.12 (559)

2020

Volltextzugriff (PDF)

TRACERx: Tracking tumor evolution to impact the course of lung cancer

The Journal of thoracic and cardiovascular surgery, 2018-03, Vol.155 (3), p.1199-1202

2018

Volltextzugriff (PDF)

Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma

Anti-cancer drugs, 2017-09, Vol.28 (8), p.915-921

2017

Volltextzugriff (PDF)

Aerobic exercise training combined with local strength exercise restores muscle blood flow and maximal aerobic capacity in long-term Hodgkin lymphoma survivors

American journal of physiology. Heart and circulatory physiology, 2024-06, Vol.326 (6), p.H1462-H1468

2024

Volltextzugriff (PDF)

Clinical outcomes of chemotherapy rechallenge in patients with metastatic non-small cell lung (NSCLC) who progressed on immunotherapy maintenance after front line platinum doublets and immunotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21205-e21205

2023

Volltextzugriff (PDF)

Safety and efficacy of Sleeping Beauty TCR-T cells targeting shared KRAS and TP53 mutations expressed by solid tumors in first-in-human phase 1 study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2547-2547

2023

Volltextzugriff (PDF)

The Cancer Genome Atlas findings in head and neck cancer: a renewed hope

Current opinion in oncology, 2014-05, Vol.26 (3), p.245-246

2014

Volltextzugriff (PDF)

SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC

Journal of clinical oncology, 2024-08, Vol.42 (23_suppl), p.TPS218-TPS218

2024

Volltextzugriff (PDF)

Activity of adagrasib (MRTX849) in patients with KRAS G12C -mutated NSCLC and active, untreated CNS metastases in the KRYSTAL-1 trial

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA9009-LBA9009

2022

Volltextzugriff (PDF)

First-in-human phase 1/2 study of autologous T cells engineered using the Sleeping Beauty System transposon/transposase to express T-cell receptors (TCRs) reactive against cancer-specific mutations in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2679-TPS2679

2022

Volltextzugriff (PDF)

Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9105-9105

2022

Volltextzugriff (PDF)

Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21072-e21072

2023

Volltextzugriff (PDF)

KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C -mutated solid tumors including non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9007-9007

2023

Volltextzugriff (PDF)

Abstract 2956: Mechanisms of resistance for osimertinib for patients with EGFR -mutant lung cancer: MD Anderson Cancer Center single institution experience with osimertinib resistance

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2956-2956

2018

Volltextzugriff (PDF)

Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21169-e21169

2022

Volltextzugriff (PDF)

Deep learning signature from chest CT and association with immunotherapy outcomes in EGFR/ALK-negative NSCLC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9061-9061

2022

Volltextzugriff (PDF)

Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9049-9049

2022

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(11)
Oncology
(9)
Female
(8)
Adult
(6)
Male
(5)
Retrospective Studies
(5)
Middle Aged
(4)
Aged
(3)
Cardiac & Cardiovascular Systems
(3)
Cardiovascular System & Cardiology
(3)
Cell Biology
(3)
Chemotherapy
(3)
Time Factors
(3)
Toxicity
(3)
Antineoplastic Agents - Adverse Effects
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cervical Cancer
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?

Immature uterine teratoma associated with uterine inversion

Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer

Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection

Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis

Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

TRACERx: Tracking tumor evolution to impact the course of lung cancer

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma

Aerobic exercise training combined with local strength exercise restores muscle blood flow and maximal aerobic capacity in long-term Hodgkin lymphoma survivors

Clinical outcomes of chemotherapy rechallenge in patients with metastatic non-small cell lung (NSCLC) who progressed on immunotherapy maintenance after front line platinum doublets and immunotherapy

Safety and efficacy of Sleeping Beauty TCR-T cells targeting shared KRAS and TP53 mutations expressed by solid tumors in first-in-human phase 1 study

The Cancer Genome Atlas findings in head and neck cancer: a renewed hope

SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC

Activity of adagrasib (MRTX849) in patients with KRAS G12C -mutated NSCLC and active, untreated CNS metastases in the KRYSTAL-1 trial

First-in-human phase 1/2 study of autologous T cells engineered using the Sleeping Beauty System transposon/transposase to express T-cell receptors (TCRs) reactive against cancer-specific mutations in patients with advanced solid tumors

Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC)

Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

KontRASt-01 update: Safety and efficacy of JDQ443 in KRAS G12C -mutated solid tumors including non-small cell lung cancer (NSCLC)

Abstract 2956: Mechanisms of resistance for osimertinib for patients with EGFR -mutant lung cancer: MD Anderson Cancer Center single institution experience with osimertinib resistance

Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma

Deep learning signature from chest CT and association with immunotherapy outcomes in EGFR/ALK-negative NSCLC

Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study

Suchergebnisse filtern